James Meikle currently serves as the Director of Corporate Development and Investor Relations at Eupraxia Pharmaceuticals Inc., a position held since August 2025. Prior to this role, James was the Director of Business Development and Corporate Strategy at Aequus Pharmaceuticals from December 2020 to August 2025, and also held the position of Senior Business Analyst in Business Development. James's earlier experiences include roles at AstraZeneca as a Medical Sales Representative and Business Unit Analytics Manager in Respiratory, as well as a Customer Strategy Analyst at Roche. James began his career at Johnson & Johnson Innovative Medicine, initially as an intern and later as an Associate in Government Affairs and Market Access. Other internships and roles include work with Crohn's and Colitis Canada, Providence Health & Services, and the University of British Columbia. James holds a Master of Biotechnology from the University of Toronto and a Bachelor of Science in Biochemistry with an Arts Minor in Economics from Queen's University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices